Integrated regulatory governance engineered directly into clinical trial architecture and dossier publishing.
eCTD Dossier Publishing
Clinical Risk Mitigation
Safety Protocol Design
Rigorous electronic common technical document compiling for seamless agency acceptance and zero validation delays.
Proactive gap analysis identifying agency review friction before protocols are finalized for human trials.
Structuring pharmacovigilance and safety data streams to meet stringent FDA and EMA regulatory thresholds.
Proven Submission Performance
100%
First-pass dossier acceptance rate
0
Clinical hold delays on IND submissions
45+
FDA and EMA agency filings approved
Structured Filing Execution
Pre-IND Strategy & Gap Analysis
Protocol Engineering & Safety Metrics
eCTD Dossier Authoring & Validation
Agency Engagement & Post-Filing Care
Evaluating trial data and alignment with agency expectations before early-stage clinical initiation.
Embedding endpoints and regulatory milestones into active phase 1 through 3 protocol architecture.
Compiling technical dossiers with rigorous cross-referencing and XML standard publishing.
Managing regulatory inquiries, rapid response turnarounds, and commercial lifecycle maintenance.
Partner with direct embedded regulatory strategists to prepare your upcoming FDA or EMA filing.